Early Detection of Pancreatic Cancer - A Defined Future Using Lessons from Other Cancers: A White Paper

Barbara J. Kenner, Suresh T Chari, Anirban Maitra, Sudhir Srivastava, Deborah F. Cleeter, Vay Liang W Go, Laura J. Rothschild, Ann E. Goldberg

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The implementation of effective early detection programs has significantly improved treatment, prognosis, and life expectancy in breast, prostate, and colorectal cancers. Early-detection methods need to be developed for pancreatic ductal adenocarcinoma (PDAC), where progress during the past decades has remained slow. Addressing this need, the forum "Early Detection: Lessons Learned from Other Cancers" was held in November 2015 and presented by the Kenner Family Research Fund in partnership with the American Pancreatic Association. Leading experts from breast, prostate, and colorectal cancers described the development of early detection methods in their respective fields. Emerging opportunities for scientific advancement were subsequently identified that hold the greatest promise for the future of early detection in PDAC, including a 4-part strategic map of necessary actionable items. Knowledge from other fields must be applied to achieve large-scale change within the arena of PDAC. A major breakthrough in early detection of PDAC will occur only through a definitive interdisciplinary collaborative effort involving a critical mass of committed academic research institutions, government agencies, industry leaders, and philanthropies.

Original languageEnglish (US)
Pages (from-to)1073-1079
Number of pages7
JournalPancreas
Volume45
Issue number8
DOIs
StatePublished - Sep 1 2016

Fingerprint

Pancreatic Neoplasms
Early Detection of Cancer
Adenocarcinoma
Colorectal Neoplasms
Neoplasms
Prostatic Neoplasms
Breast Neoplasms
Government Agencies
Life Expectancy
Industry
Research

Keywords

  • early detection
  • high-risk group
  • new-onset diabetes
  • pancreatic ductal adenocarcinoma
  • screening

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

Kenner, B. J., Chari, S. T., Maitra, A., Srivastava, S., Cleeter, D. F., Go, V. L. W., ... Goldberg, A. E. (2016). Early Detection of Pancreatic Cancer - A Defined Future Using Lessons from Other Cancers: A White Paper. Pancreas, 45(8), 1073-1079. https://doi.org/10.1097/MPA.0000000000000701

Early Detection of Pancreatic Cancer - A Defined Future Using Lessons from Other Cancers : A White Paper. / Kenner, Barbara J.; Chari, Suresh T; Maitra, Anirban; Srivastava, Sudhir; Cleeter, Deborah F.; Go, Vay Liang W; Rothschild, Laura J.; Goldberg, Ann E.

In: Pancreas, Vol. 45, No. 8, 01.09.2016, p. 1073-1079.

Research output: Contribution to journalArticle

Kenner, BJ, Chari, ST, Maitra, A, Srivastava, S, Cleeter, DF, Go, VLW, Rothschild, LJ & Goldberg, AE 2016, 'Early Detection of Pancreatic Cancer - A Defined Future Using Lessons from Other Cancers: A White Paper', Pancreas, vol. 45, no. 8, pp. 1073-1079. https://doi.org/10.1097/MPA.0000000000000701
Kenner, Barbara J. ; Chari, Suresh T ; Maitra, Anirban ; Srivastava, Sudhir ; Cleeter, Deborah F. ; Go, Vay Liang W ; Rothschild, Laura J. ; Goldberg, Ann E. / Early Detection of Pancreatic Cancer - A Defined Future Using Lessons from Other Cancers : A White Paper. In: Pancreas. 2016 ; Vol. 45, No. 8. pp. 1073-1079.
@article{fd30c471d5a94c8785c7ebb5291da139,
title = "Early Detection of Pancreatic Cancer - A Defined Future Using Lessons from Other Cancers: A White Paper",
abstract = "The implementation of effective early detection programs has significantly improved treatment, prognosis, and life expectancy in breast, prostate, and colorectal cancers. Early-detection methods need to be developed for pancreatic ductal adenocarcinoma (PDAC), where progress during the past decades has remained slow. Addressing this need, the forum {"}Early Detection: Lessons Learned from Other Cancers{"} was held in November 2015 and presented by the Kenner Family Research Fund in partnership with the American Pancreatic Association. Leading experts from breast, prostate, and colorectal cancers described the development of early detection methods in their respective fields. Emerging opportunities for scientific advancement were subsequently identified that hold the greatest promise for the future of early detection in PDAC, including a 4-part strategic map of necessary actionable items. Knowledge from other fields must be applied to achieve large-scale change within the arena of PDAC. A major breakthrough in early detection of PDAC will occur only through a definitive interdisciplinary collaborative effort involving a critical mass of committed academic research institutions, government agencies, industry leaders, and philanthropies.",
keywords = "early detection, high-risk group, new-onset diabetes, pancreatic ductal adenocarcinoma, screening",
author = "Kenner, {Barbara J.} and Chari, {Suresh T} and Anirban Maitra and Sudhir Srivastava and Cleeter, {Deborah F.} and Go, {Vay Liang W} and Rothschild, {Laura J.} and Goldberg, {Ann E.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1097/MPA.0000000000000701",
language = "English (US)",
volume = "45",
pages = "1073--1079",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Early Detection of Pancreatic Cancer - A Defined Future Using Lessons from Other Cancers

T2 - A White Paper

AU - Kenner, Barbara J.

AU - Chari, Suresh T

AU - Maitra, Anirban

AU - Srivastava, Sudhir

AU - Cleeter, Deborah F.

AU - Go, Vay Liang W

AU - Rothschild, Laura J.

AU - Goldberg, Ann E.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - The implementation of effective early detection programs has significantly improved treatment, prognosis, and life expectancy in breast, prostate, and colorectal cancers. Early-detection methods need to be developed for pancreatic ductal adenocarcinoma (PDAC), where progress during the past decades has remained slow. Addressing this need, the forum "Early Detection: Lessons Learned from Other Cancers" was held in November 2015 and presented by the Kenner Family Research Fund in partnership with the American Pancreatic Association. Leading experts from breast, prostate, and colorectal cancers described the development of early detection methods in their respective fields. Emerging opportunities for scientific advancement were subsequently identified that hold the greatest promise for the future of early detection in PDAC, including a 4-part strategic map of necessary actionable items. Knowledge from other fields must be applied to achieve large-scale change within the arena of PDAC. A major breakthrough in early detection of PDAC will occur only through a definitive interdisciplinary collaborative effort involving a critical mass of committed academic research institutions, government agencies, industry leaders, and philanthropies.

AB - The implementation of effective early detection programs has significantly improved treatment, prognosis, and life expectancy in breast, prostate, and colorectal cancers. Early-detection methods need to be developed for pancreatic ductal adenocarcinoma (PDAC), where progress during the past decades has remained slow. Addressing this need, the forum "Early Detection: Lessons Learned from Other Cancers" was held in November 2015 and presented by the Kenner Family Research Fund in partnership with the American Pancreatic Association. Leading experts from breast, prostate, and colorectal cancers described the development of early detection methods in their respective fields. Emerging opportunities for scientific advancement were subsequently identified that hold the greatest promise for the future of early detection in PDAC, including a 4-part strategic map of necessary actionable items. Knowledge from other fields must be applied to achieve large-scale change within the arena of PDAC. A major breakthrough in early detection of PDAC will occur only through a definitive interdisciplinary collaborative effort involving a critical mass of committed academic research institutions, government agencies, industry leaders, and philanthropies.

KW - early detection

KW - high-risk group

KW - new-onset diabetes

KW - pancreatic ductal adenocarcinoma

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=84983391852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983391852&partnerID=8YFLogxK

U2 - 10.1097/MPA.0000000000000701

DO - 10.1097/MPA.0000000000000701

M3 - Article

C2 - 27518362

AN - SCOPUS:84983391852

VL - 45

SP - 1073

EP - 1079

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 8

ER -